Stent versus drug-coated balloon for blocked coronary artery branches
Part of Heart & circulation clinical trials.
This trial compares two ways to treat a coronary artery blockage at a fork (bifurcation): one uses a standard stent, the other uses a special balloon that releases medication to keep the artery open. It aims to find which approach is safer and more effective for patients with this specific type of blockage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a narrowed coronary artery at a branching point, with the blockage affecting both the main vessel and the side branch.
- The blockage is causing symptoms like chest pain or is shown to be limiting blood flow by tests.
- The side branch is at least 2.5 mm wide and about 73 mm long.
- You are at least 18 years old and can give informed consent.
- You have not had a severe heart attack (STEMI) within the last 48 hours, are not in cardiogenic shock, and have decent heart function.
- You have not had prior stent treatment in the same area and no more than two other coronary blockages that need treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to treat blocked heart arteries at a branching point: placing a small metal mesh tube (stent) versus using only a special balloon coated with medicine. The goal is to see which approach keeps the artery open better and is safer for patients.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two ways of placing a stent at the point where the main left artery splits into two branches. It is for people who have a blockage in the very beginning of one of those branches, and it uses advanced drug-eluting stents to see which method works better.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial compares two ways to open blocked heart arteries: a drug-coated balloon (a small balloon that releases medicine) versus a drug-eluting stent (a tiny mesh tube that also releases medicine). It aims to find which option works better for people with relatively simple blockages.
Hear when a new Coronary Bifurcation Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.